Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the bioequivalence of Roxane Laboratories'
Calcitriol capsules, 0.25 mcg, to ROCALTROL® capsules, 0.25 mcg (Roche) using a single-dose,
2-treatment, 2-period, crossover design, under fasting conditions